
































1Developmental Cognitive Neuroscience 16 (2015) 1–4
Contents lists available at ScienceDirect
Developmental Cognitive  Neuroscience
j o ur nal ho me  pa ge: ht tp : / /www.e lsev ier .com/ locate /dcn
ntroduction  to  the  special  issue:  Substance  use  and  the  adolescent
rain:  Developmental  impacts,  interventions,  and  longitudinal
utcomes





a  b  s  t  r  a  c  t
Adolescent  substance  abuse  is a major  public  health  problem,  particularly  given  the  negative  brain  and
behavioral  consequences  that  often  occur  during  and  following  acute  intoxication.  Negative  outcomes
appear  to  be especially  pronounced  when  substance  use  is  initiated  in the  early  adolescent  years,  per-
haps  due  to neural  adaptations  that  increase  risk  for  substance  use  disorders  into  adulthood.  Recent
models  to explain  these  epidemiological  trends  have  focused  on  brain-based  vulnerabilities  to  use  as
well  as  neurodevelopmental  aberrations  associated  with  initiation  of  use  in substance  naïve  samples
or  through  the  description  of case-control  differences  between  heavy  users  and controls.  Within  this
research,  adolescent  alcohol  and  marijuana  users  have  shown  relative  decreases  in regional  gray  matter
volumes,  substance-speciﬁc  alterations  in  white  matter  volumes,  deviations  in microstructural  integrity
in  white  matter  tracts  that  regulate  communication  between  subcortical  areas  and  higher  level  regula-
tory  control  regions,  and  deﬁcits  in  functional  connectivity.  How  these  brain  anomalies  map  onto  other
types  of youth  risk  behavior  and later  vulnerabilities  represent  major  questions  for continued  research.
This  special  issue  addresses  these  compelling  and timely  questions  by introducing  new  methodologies,
empirical  relationships,  and  perspectives  from  major  leaders  in  this  ﬁeld.
©  2015  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-NDAberrant patterns of substance use have long been recognized
s a signiﬁcant clinical and public health problem. Among adults,
ubstance use problems are quite common (Kessler et al., 2005;
erikangas and McClair, 2012). Recent surveys indicate that 7.8%
f U.S. adults over the age of 18 had one or more substance use
isorders in the past year (http://www.samhsa.gov/data/sites/
efault/ﬁles/NSDUH-DR-N2MentalDis-2014-1/Web/NSDUH-DR-
2MentalDis-2014.htm), largely driven by alcohol use problems.
t is broadly perceived that substance use, as a privileged behavior,
an readily escalate out of one’s control in the absence of appropri-
te behavioral boundaries. Indeed, a large percentage of the world
opulation has struggled with substance use disorders at some
oint within their lifetime (Whiteford et al., 2015). Data from the
onitoring the Future study (Johnston et al., 2013), funded by the
.S. National Institute on Drug Abuse, consistently indicate that
arijuana is the most commonly used illicit substance, a pattern
hat reﬂects worldwide trends (http://www.who.int/substance
buse/facts/psychoactives/en/). Within the United States, sub-
tances such as alcohol and nicotine can be legally purchased and
ngested in public places at the age of 21; in most of Europe and
he UK, the legal drinking age is 18. The legalization of recreational
arijuana use is much more recent, and within the United States,
ighly controversial. At the time of this writing, four States (Oregon,
ashington, Colorado, Alaska) and the District of Columbia have
ttp://dx.doi.org/10.1016/j.dcn.2015.10.005
878-9293/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article unlicense  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
legalized recreational marijuana use and 23 States plus the District
of Columbia have legalized use for medical purposes (https://
www.whitehouse.gov/ondcp/state-laws-related-to-marijuana).
Importantly, however, legalization is not yet recognized at the
federal level, subsequently resulting in some degree of conﬂict
around the “acceptability” of this substance use behavior. More
importantly, in the interim, it is feared that increasing access
to this drug for many individuals, including adolescents, may
represent an unforeseen consequence of legalized medical use
(Cerdá et al., 2012; Harper et al., 2012). In other Western countries,
such as the United Kingdom and European Union, the age at which
one can legally use alcohol, nicotine, and marijuana varies. In the
Netherlands, for example, cannabis can be legally purchased only
in designated coffeeshops whereas alcohol can be legally used at
any age but can be purchased at age 18.
Within the scientiﬁc community, the manner in which these
standards that regulate access are adopted and enforced inspires
debate, because while it is recognized that experimentation with
such substances is highly typical for many adolescents and often
time-limited (naturally remitting by mid-adulthood, concurrent
with youths’ adoption of more “adult” responsibilities; Shedler and
Block, 1990), earlier ﬁrst-time users of alcohol and marijuana show
elevated risks of developing substance use disorders in adulthood
(Johnston et al., 2013). Moreover, recent reviews have shown that

































































i Introduction to the special issue: Substance use and the adole
ven modest levels of alcohol use can be linked to differences
n neural structure and function during adolescence (e.g., Bava
t al., 2013; Elofson et al., 2013; Feldstein Ewing et al., 2014),
nd similar trends are evident for marijuana (Batalla et al., 2013;
attistella et al., 2014). Moreover, the use of alcohol and marijuana
n large quantities has been associated with cognitive problems,
articularly in the areas of learning and memory, attention, and
xecutive function (Becker et al., 2014; Bossong et al., 2014; Crean
t al., 2011; Dougherty et al., 2013). At least one longitudinal
tudy suggests that chronic marijuana use, particularly when use
egins in adolescence, leads to later declines in general intellectual
unction (Meier et al., 2012), and similar ﬁndings are reported
n relation to more speciﬁc domains of cognition (Fontes et al.,
011). Negative outcomes are particularly salient in the contexts
f earlier use onset (<age 16 years; Gruber et al., 2012, 2014) as
ell as heavier and more frequent use (Bolla et al., 2002; Filbey
t al., 2014; Solowij and Grenyer, 2002). Binging behavior, most
ften studied in relation to alcohol use, may  be one of the most
ernicious contributors to persistent structural and functional
bnormalities across preclinical (Crabbe et al., 2011; Risher et al.,
015) and human studies (George et al., 2012; Squeglia et al., 2011).
Despite such ﬁndings, the “chicken versus egg” question still
emains one of the most vexing in this ﬁeld. It may  be that indi-
iduals carry genetic liabilities for substance misuse and related
ifﬁculties (Kendler et al., 2003). Such liabilities may  lead to an
ncreased risk of substance use initiation and escalation as well
s associated problems. Alternatively, negative outcomes associ-
ted with substance misuse may  be directly caused by the impact
f substances on developing neural systems and the downstream
ehavioral impacts of this type of impaired neural activity (Koob
nd Volkow, 2010). Further, it is possible, if not highly likely,
hat there is some degree of interaction. For example, it might be
he case that substance use disorders represent diathesis/stress
ssociations or gene/environment correlations, wherein certain
ndividuals have a greater risk of developing SUDs based on genetic
ulnerabilities (e.g., family history of substance use; risky “reward”
eural structure/circuitry) that are “activated” or “exacerbated”
y the introduction of substance use during the developing ado-
escent years (cf., Cadoret et al., 1986; Hayatbakhsh et al., 2012;
acono et al., 2008). Alternately, what we are observing could be
n epigenetic phenomenon, such that substance use during ado-
escence might not change genetic hardwiring, but may  instead
lter gene expression (e.g., methylation) in critical regions, conse-
uently changing neural structure/function, and youths’ capacity
or decision-making around risk contexts, including those that
ring opportunities for substance use (Nestler, 2014). Most likely,
ach of these processes are relevant wherein biologically vulner-
ble individuals, already distinct in measurable ways prior to use
nset, engage in substance use and are then further impacted by
oxic effects of the substances. It is thus important to ascertain
hich traits, characteristics and contextual factors render indi-
iduals vulnerable to use prior to initiation, the speciﬁc avenues
hrough which each substance exerts its effects on the brain, and
hen and within which neural circuits substance exposure has the
aximum negative impacts. Developmental cognitive and affec-
ive neuroscientiﬁc investigations are uniquely situated to examine
hese issues.
One of the more critical contextual inﬂuences at hand is the
vailability and prevalence of substances of abuse, increasing the
ikelihood that individuals will select substance use as a risk behav-
or of choice. For example, in the United States, by age 18, 75.6%
f adolescents have used alcohol, 48.6% have used cannabis, and
8.1% have used tobacco (with increasing percentages using elec-
ronic cigarettes, up to 20.6%) (Kann et al., 2014). Subsequently,
f commonly-used substances such as alcohol, nicotine, and mar-
juana are toxic to developing neural tissues, then we  can readilybrain / Developmental Cognitive Neuroscience 16 (2015) 1–4
anticipate that such effects could cause the most disruption during
periods of pronounced and rapid neural development. Fetal alcohol
syndrome provides a compelling illustration of this phenomenon
wherein alcohol exposure to the developing fetus has signiﬁcant,
long-standing, negative health sequelae that impede a young per-
son across physical, cognitive, and behavioral domains throughout
the lifespan (Stratton et al., 1996; Wozniak et al., 2006). Similarly,
there is evidence that heavy substance use, including use of alcohol
(Oscar-Berman and Marinkovic, 2007) and cocaine (Ersche et al.,
2012) accelerates the human aging process. Heavy users exhibit
atrophy of cortical tissue at a rate that exceeds that of non-users
(Ersche et al., 2012; Fortier et al., 2011). Whether such associations
are evident in other periods such as adolescence, when the brain
is actively developing in more subtle ways (Lebel and Beaulieu,
2011; Lebel et al., 2012; Gogtay and Thompson, 2010; Urosevic
et al., 2012), or the degree to which normative, smaller (quantity)
or shorter (duration) experimental levels of use confer deﬁcits is
far from fully understood. However, recent ﬁndings (Bava et al.,
2013; Filbey et al., 2014; Luciana et al., 2013) as well as the papers
in this issue support that heavy substance use during adolescent
neurodevelopment has long-range consequences.
Certainly, from a public health standpoint, there is an impetus
to ﬁnd and report deﬁcits associated with adolescent sub-
stance use. Substance use is strongly linked to a panoply of
other risk behaviors including, other and heavier types of sub-
stance use initiation, other types of risk behaviors, externalizing
disorders, and disruptions in school, family, and social func-
tioning (Feldstein and Miller, 2006; Feldstein Ewing et al.,
2015a,b). Moreover, alcohol use is one the main contributors
to the incidence of accidents and injuries during adolescence
(Miller et al., 2007), which represents the leading cause of morbid-
ity and mortality in this age group (American Academy of Pediatrics,
2010). Yet, while it seems intuitive that substance use may  be the
vehicle driving the connections among risk-taking propensity, dis-
ruptions in cortical function/structure, and future risk for substance
use disorder, these associations and their temporal trajectories are
far from established. Instead, the notion that addiction emerges
through the impact of substances on the brain remains quite con-
troversial (Volkow and Koob, 2015).
One reason for the lack of certainty in this area is that histori-
cally, studies of substance-using populations have been plagued by
methodological shortcomings that render objective interpretation
of existing ﬁndings difﬁcult and call extant ﬁndings and potential
contributing factors into question. For example, in the absence of
prospective studies, it is virtually impossible to identify and disen-
tangle individual differences in cognition and affect that may have
existed prior to onset of substance use. Further, even within the
psychosocial literature, large-scale, long-term (7 year) longitudinal
studies of high-risk individuals are still trying to determine which
factors (e.g., peers, family factors, neuropsychology) have the most
impact in predicting who  is most likely to continue using alcohol
and marijuana (Feldstein Ewing et al., 2015b). We  also have very lit-
tle information about how, when, and why youth begin to use (e.g.,
D’Amico and McCarthy, 2006), and even less data on how very early
use (prior to age 16) impacts developing brain and behavior. Anec-
dotally, many former users (now adults) question whether their
teenage indiscretions have consequences into middle and older
age. Few studies (but see Hanson et al., 2010) address functional
improvements that may  evolve with abstinence.
Ultimately, at this time, the broader body of literature highlights
predominantly cross-sectional studies of single-aspects of sub-
stance use or related correlates that suggest substance use is “bad”
for brain and broader health. Most of these compare users versus
non-users, without considering how users might have already been
a distinct subgroup (e.g., signiﬁcant differences across behavior
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se initiation). Second, even in longitudinal work, it can be difﬁ-
ult in the absence of sophisticated modeling techniques and very
arge samples to quantitatively determine the relative contribution
f genetic vs. environmental factors on brain structure/function,
nd related behavioral outcomes. The ﬁeld is only beginning to
se more sophisticated methodological approaches to incorporate
imultaneous consideration of multi-dimensional traits or features
f behavior, such as elevated levels of impulsivity, high sensation-
eeking, and poor executive function. This more collective, holistic
pproach, particularly with methods from developmental neuro-
cience, is likely to give us a better sense of who is most impacted by
roblem substance use, and who is most likely to continue use into
dulthood. Capturing nuances of neurodevelopment and function
rior to substance use onset is essential. Once an individual reaches
he point of a diagnosable substance use disorder, it is much more
ifﬁcult to disentangle co-occurring other psychopathology, as it is
ighly typical for other major psychological problems (e.g., exter-
alizing disorders) to be present by adulthood (Iacono et al., 2008).
he impact of comorbid conditions on observed neurodevelopmen-
al outcomes is not well-characterized in the current developmen-
al neuroscience literature. Third, we are far from understanding
hether brain-based anomalies observed in users are true differ-
nces attributable to substance use, predisposing factors, and/or
rtifacts of a particular study design. Lack of replicability is a major
ssue (Baker, 2015). Further, we have little sense of the behavioral
igniﬁcance of observed anomalies. For example, among substance
sers, certain brain differences might, in fact, represent compen-
atory strategies (Schweinsburg et al., 2005, 2011); the degree to
hich these compensatory strategies might be adaptive is not yet
nown (Giedd, 2015). Broader looks across the literature have con-
rmed the need for full context. In a recent study and meta-analytic
eview, Weiland et al. (2015) concluded, in fact, that daily mar-
juana use was not associated with morphometric brain changes
n adolescents or adults. In their report, it was noted that among
ublished studies, half report ﬁndings of increases in regional
rain volumes in daily cannabis users while the other half report
ecreases; overall the mean effect size appears to be minimal.
Overall, recognition of these interpretive dilemmas challenges
s, as a ﬁeld, to improve methodology and remain cognizant of the
mpact of relevant limitations on our interpretations of the extant
ata. Without a full picture of how substance using youth are func-
ioning in the broader domains of peers, school, and family, it can be
empting to infer that any observed difference between substance
sers and non-users represents a negative outcome. Assessment of
hese real-world behavioral anchors is requisite to fully understand
ow neural adaptations relate to not only risk, but also function,
cross the contexts of use and in longer term neurobehavioral
evelopment.
Our goal in organizing this special issue is to present cutting edge
esearch in this area. The twenty papers published here present
ew empirical research, incorporating cognitive and affective neu-
oscientiﬁc methods, from leading laboratories where brain-based
utcomes associated with adolescent substance use are a focus of
nquiry. Among these papers, 8 present data from longitudinal stud-
es, and two of these (Serlin et al.; Saalﬁeld et al.) present data from
nimal models. Longitudinal data are important in addressing the
onger-term neurodevelopmental consequences associated with
ubstance misuse. The paper by Wilson et al. is notable for its use
f a cutting edge behavior genetic approach (the co-twin control
esign) to disentangle toxic effects of alcohol from genetic predis-
ositions. A large number of the empirical papers in the issue (8
f 20) concentrate on marijuana and its effects on brain structure,
unction, and connectivity. Many are notable for their attempts to
ssess the inﬂuence of risk factors on salient outcomes, includ-
ng age of substance use onset (Becker et al.; Filbey et al.; Gruber
t al.; Lopez-Larson et al.), binge use patterns (Cservenka et al.),rain / Developmental Cognitive Neuroscience 16 (2015) 1–4 3
family history (Cohen-Gilbert et al.), polysubstance use (Karoly
et al.), histories of prenatal exposure (Gautam et al.), and execu-
tive dysfunction (Peeters et al.). As a comprehensive body of work,
the sum of these data underscore the salient impact of adolescent
substance use on the brain’s reward system as a compelling area of
inquiry (cf., Karoly et al.; Weissman et al.), along with the assess-
ment of how threat-based motivation is impacted by use (Spechler
et al.; Heitzig et al.). These papers call attention to the need to incor-
porate more basic translational science into this area of inquiry. Our
commentators, Boyce, Brown and Giedd, bring unique perspectives
from clinical, public health, and developmental standpoints to the
ﬁndings.
Overall, the issue offers a timely collection of papers that address
the empirical connections between adolescent substance use and
developing brain structure/volume by leaders in the ﬁeld. Strengths
include the large number of longitudinal studies, the use of methods
from the cognitive and affective neuroscientiﬁc literatures guid-
ing inquiry into speciﬁc brain circuits and processes impacted by
use, consideration of neurochemical as well as structural brain
outcomes (cf., Cohen-Gilbert et al.), and the examination of both
premorbid risk factors as well as substance-speciﬁc “toxic” out-
comes. As noted by several authors (cf., Becker et al., 2014), the
search for behavioral correlates remains challenging outside of the
realm of substance use-related behavioral patterns such as age of
substance use onset.
We hope that this collection will be a critical resource at this
pivotal time as policy-makers within larger-scale organizations
(government agencies) render decisions about how to implement
legal policy related to this privileged behavior, monitor outcomes,
and evaluate patterns of substance use in young adults as well as
adolescents.
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